XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
3.020
+0.030 (1.00%)
Feb 24, 2025, 10:01 AM EST - Market open
XBiotech Market Cap
XBiotech has a market cap or net worth of $92.06 million as of February 24, 2025. Its market cap has decreased by -44.21% in one year.
Market Cap
92.06M
Enterprise Value
-77.40M
1-Year Change
-44.21%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $92.06M, a decrease of -87.52%. That is a compound annual growth rate of -19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 91.10M | -24.34% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |